U.S. eases opioid addiction treatment through buprenorphine medication
Category: #headlines  By Pranali Mehta  Date: 2021-04-29
  • share
  • Twitter
  • Facebook
  • LinkedIn
U.S. eases opioid addiction treatment through buprenorphine medication

The U.S. government led by President Joe Biden is working on simplifying decade-old requirements that complicate the treatment of opioid addiction for doctors through medication. Notably, as per the new guidelines, doctors and healthcare professionals will no longer require extra hours of training to prescribe buprenorphine – a leading medication that helps deal with the drugs cravings. Moreover, they no longer have to refer patients to undergo counseling sessions.

As per the relaxed guidelines, the medical workers will be able to treat nearly 30 patients at a time with the help of the drug which comes in the form of a pill or a film that dissolves when placed under the tongue. Priced at approximately USD 100 a month, the most common type of buprenorphine is suboxone. 

It is worth mentioning that, owing to how opioids perform on the brain, people consuming it get sick once they stop consuming it. Withdrawal symptoms may include sleeplessness, sweating, anxiety, and bad flu along with cramps. Cravings for the drug are so intense that relapses are very common.

Buprenorphine helps in such cases by shifting the patient from high-dose painkillers or an illegal opioid-like heroine to a regular cycle of an opioid-based drug. Apart from doctors, physician assistants, nurse practitioners, certified nurse midwives, and other types of nurses will be allowed to prescribe buprenorphine without gaining any specialized training.

According to Brendan Saloner, an addiction researcher at the Johns Hopkins Bloomberg School of Public Health, the new step will particularly help to ramp up treatments in hospitals, healthcare units, prisons, and jails where large cases of people with addiction exist.

Although to treat over 30 patients at a time, stricter regulations will remain for the prescribers. In the past, the former Trump administration tried to introduce a similar change in its final days but it was only applicable to doctors. Seemingly, the Biden administration held the matter for a legal and policy review, later deciding on expanding the relaxed rules to more prescribers.

Source Credit: https://www.wionews.com/world/us-lifts-barriers-to-prescribing-addiction-treatment-drug-380949

 

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Pranali Mehta

Pranali Mehta    

Pranali Mehta boasts of over three years of experience as a content writer. Having completed her graduation in chemical engineering, she worked as safety & environment associate in a chemical company for a year. Harnessing her passion for writing however, Pranali deci...

Read More >>

More News By Pranali Mehta

Indian fintech startup Clear secures USD 75 million in Series C funding
Indian fintech startup Clear secures USD 75 million in Series C funding
By Pranali Mehta

Clear (earlier known as ClearTax) has reportedly secured USD 75 million in a Series C funding round, which was led by Kora Capital. The latest funding round also saw participation from global fintech giant Stripe, Think Investments, Alua Capital, and...

CredAble bags USD 30 Mn Series B funding to expand product portfolio
CredAble bags USD 30 Mn Series B funding to expand product portfolio
By Pranali Mehta

Financing company CredAble recently raised USD 30 million in Series B funding to further develop its platform for providing working capital solutions especially for small businesses and developing innovative debt capital products for corporates and f...

FourKites launches new AI-based Dynamic ETA® for Ocean Shipping
FourKites launches new AI-based Dynamic ETA® for Ocean Shipping
By Pranali Mehta

FourKites, one of the world's leading real-time supply chain prominence platforms, has introduced an innovative industry-first AI-powered Dynamic ETA® for Ocean, as part of its Dynamic OceanSM contribution. As per sources, the new addition o...